Immediate Impact
3 from Science/Nature 71 standout
Citing Papers
Exploring treatment options in cancer: tumor treatment strategies
2024 Standout
The anti-PD-L1/CTLA-4 bispecific antibody KN046 in combination with nab-paclitaxel in first-line treatment of metastatic triple-negative breast cancer: a multicenter phase II trial
2024 Standout
Works of Débora Barton being referenced
A phase 1, first-in-human (FIH) study of the anti-HER2 CAR macrophage CT-0508 in subjects with HER2 overexpressing solid tumors.
2022
nab-Paclitaxel plus carboplatin or gemcitabine versus gemcitabine plus carboplatin as first-line treatment of patients with triple-negative metastatic breast cancer: results from the tnAcity trial
2018
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Débora Barton | 219 | 68 | 12 | 94 | 80 | 26 | 285 | |
| Manjari Pandey | 159 | 65 | 10 | 94 | 61 | 20 | 317 | |
| Marta Popęda | 133 | 47 | 12 | 72 | 85 | 30 | 324 | |
| Daniela Bianconi | 159 | 51 | 10 | 64 | 73 | 23 | 301 | |
| Songwei Feng | 80 | 57 | 23 | 73 | 66 | 21 | 251 | |
| Feifei Gu | 85 | 66 | 10 | 62 | 59 | 25 | 250 | |
| Nazia Riaz | 120 | 38 | 11 | 76 | 77 | 29 | 250 | |
| Zhenrong Tang | 134 | 21 | 15 | 76 | 129 | 29 | 293 | |
| Farid Ghorbaninezhad | 133 | 143 | 9 | 37 | 55 | 24 | 294 | |
| Yuxian Wei | 108 | 40 | 8 | 58 | 80 | 26 | 301 | |
| Xiaoli Tian | 192 | 115 | 19 | 49 | 40 | 15 | 304 |
All Works
Loading papers...